Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
about
Insulin action in brain regulates systemic metabolism and brain function.Role of SCOX in determination of Drosophila melanogaster lifespanHypothalamic inflammation: a double-edged sword to nutritional diseases.Abnormal Glucose Metabolism in Alzheimer's Disease: Relation to Autophagy/Mitophagy and Therapeutic ApproachesMitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Modulation of Mitochondrial Dynamics in Neurodegenerative Diseases: An Insight Into Prion Diseases
P2860
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@ast
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@en
type
label
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@ast
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@en
prefLabel
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@ast
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@en
P2093
P2860
P356
P1476
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
@en
P2093
Jake G Hoekstra
Jing Zhang
Kathleen S Montine
Thomas J Montine
P2860
P2888
P356
10.1186/ALZRT83
P407
P577
2011-06-29T00:00:00Z
P5875
P6179
1024654001